Editor's Choice

doi:10.1093/humrep/dep070

Human Reproduction 2009 24(4):763; doi:10.1093/humrep/dep070

This Article

	Full Text
	FREE Full Text (PDF )
	Submit a response
	Alert me when this article is cited
	Alert me when eLetters are posted
	Alert me if a correction is posted

Services

	Email this article to a friend
	Related articles in Hum. Reprod.
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Personal Archive
	Download to citation manager
	Request Permissions

Google Scholar

	Articles by Van Steirteghem, A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Van Steirteghem, A.

Social Bookmarking

	What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Editor's Choice

André Van Steirteghem, Editor-in-Chief

E-mail: vansteirteghama@humanreproduction.co.uk

The first 10% of the full text of this article appears below.

In an Opinion paper published this month, nine clinicians fromdifferent countries enumerate why they believe ovarian hyperstimulationwith GnRH antagonists may have advantages over GnRH agonists:reduction of treatment duration, lower risk for ovarian hyperstimulationand no hypo-estrogenic adverse events since pituitary down-regulationis avoided. Probability of achieving a live birth is similarin both protocols. The authors recommend the GnRH antagonistprotocol for predicted normal responders and enumerate . . . [Full Text of this Article]

Add to CiteULike CiteULike Add to Connotea Connotea Add to Del.icio.us Del.icio.us What's this?

Related articles in Hum. Reprod.:

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment: Paul Devroey, Mohamed Aboulghar, Juan Garcia-Velasco, Georg Griesinger, Peter Humaidan, Efstratios Kolibianakis, William Ledger, Candido Tomás, and Bart C.J.M. Fauser
Hum. Reprod. 2009 24: 764-774. [Abstract] [FREE Full Text]
A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates: Marius Meintjes, Samuel J. Chantilis, David C. Ward, James D. Douglas, Alfred J. Rodriguez, Ali R. Guerami, David M. Bookout, Brian D. Barnett, and James D. Madden
Hum. Reprod. 2009 24: 782-789. [Abstract] [FREE Full Text]
Increased access to emergency contraception: why it may fail: Laura Baecher, Mark A. Weaver, and Elizabeth G. Raymond
Hum. Reprod. 2009 24: 815-819. [Abstract] [FREE Full Text]
Does low-dose aspirin improve pregnancy rate in IVF/ICSI? A randomized double-blind placebo controlled trial: K. Dirckx, P. Cabri, A. Merien, L. Galajdova, J. Gerris, M. Dhont, and P. De Sutter
Hum. Reprod. 2009 24: 856-860. [Abstract] [FREE Full Text]
Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI: a randomized, placebo-controlled, double-blind study: Mervi Haapsamo, Hannu Martikainen, and Juha Räsänen
Hum. Reprod. 2009 24: 861-866. [Abstract] [FREE Full Text]
The efficacy of the embryo transfer catheter in IVF and ICSI is operator-dependent: a randomized clinical trial: Zhan Yao, Stijn Vansteelandt, Josiane Van der Elst, Tom Coetsier, Marc Dhont, and Petra De Sutter
Hum. Reprod. 2009 24: 880-887. [Abstract] [FREE Full Text]
Infertility patients' beliefs about their embryos and their disposition preferences: V. Provoost, G. Pennings, P. De Sutter, J. Gerris, A. Van de Velde, E. De Lissnyder, and M. Dhont
Hum. Reprod. 2009 24: 896-905. [Abstract] [FREE Full Text]
Prospective longitudinal cohort study on cumulative 5-year delivery and adoption rates among 1338 couples initiating infertility treatment: A. Pinborg, C.O. Hougaard, A. Nyboe Andersen, D. Molbo, and L. Schmidt
Hum. Reprod. 2009 24: 991-999. [Abstract] [FREE Full Text]